Cibus (CBUS) Goodwill & Intangibles (2022 - 2026)
Cibus (CBUS) posted Goodwill & Intangibles of $264.2 million for Q4 2025, little changed sequentially from $264.6 million in Q3 2025, and down 7.96% YoY from $287.0 million in Q4 2024.
Cibus (CBUS) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Cibus has reported Goodwill & Intangibles for 4 years, with the latest figure at $264.2 million in Q4 2025.
- Quarterly Goodwill & Intangibles fell 7.96% year-over-year to $264.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $264.2 million (down 7.96% YoY) and the FY2025 annual result came in at $264.2 million, down 7.96% from the prior year.
- Goodwill & Intangibles was little changed at $264.2 million in Q4 2025 per CBUS's latest filing, from $264.6 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $720.6 million in Q2 2023 and troughed at $158000.0 in Q4 2022.
- A 4-year average of $373.7 million and a median of $287.3 million in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles soared 297563.92% in 2023, then tumbled 60.08% in 2024.
- Over 4 years, Goodwill & Intangibles stood at $158000.0 in 2022, then jumped by 297563.92% to $470.3 million in 2023, then sank by 38.97% to $287.0 million in 2024, then declined by 7.96% to $264.2 million in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $264.2 million, $264.6 million, and $265.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 263.29 Mn |
| Dec 31, 2025 | 264.20 Mn |
| Sep 30, 2025 | 264.65 Mn |
| Jun 30, 2025 | 265.11 Mn |
| Mar 31, 2025 | 265.56 Mn |
| Dec 31, 2024 | 287.04 Mn |
| Sep 30, 2024 | 287.50 Mn |
| Jun 30, 2024 | 469.39 Mn |
| Mar 31, 2024 | 469.85 Mn |
| Dec 31, 2023 | 470.31 Mn |
| Sep 30, 2023 | 720.19 Mn |
| Jun 30, 2023 | 720.65 Mn |
| Dec 31, 2022 | 158,000.00 |